CYP1B1 and cardiac hypertrophy: Studies have shown that CYP1B1 enzyme and its associated cardiotoxic intermediate metabolite hydroxyeicosatetraenoic acids (HETEs) exert direct effects on the development of myocardial hypertrophy [47].